Moynihan Ray, Sanders Sharon, Michaleff Zoe A, Scott Anna Mae, Clark Justin, To Emma J, Jones Mark, Kitchener Eliza, Fox Melissa, Johansson Minna, Lang Eddy, Duggan Anne, Scott Ian, Albarqouni Loai
Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia
Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia.
BMJ Open. 2021 Mar 16;11(3):e045343. doi: 10.1136/bmjopen-2020-045343.
To determine the extent and nature of changes in utilisation of healthcare services during COVID-19 pandemic.
Systematic review.
Eligible studies compared utilisation of services during COVID-19 pandemic to at least one comparable period in prior years. Services included visits, admissions, diagnostics and therapeutics. Studies were excluded if from single centres or studied only patients with COVID-19.
PubMed, Embase, Cochrane COVID-19 Study Register and preprints were searched, without language restrictions, until 10 August, using detailed searches with key concepts including COVID-19, health services and impact.
Risk of bias was assessed by adapting the Risk of Bias in Non-randomised Studies of Interventions tool, and a Cochrane Effective Practice and Organization of Care tool. Results were analysed using descriptive statistics, graphical figures and narrative synthesis.
Primary outcome was change in service utilisation between prepandemic and pandemic periods. Secondary outcome was the change in proportions of users of healthcare services with milder or more severe illness (eg, triage scores).
3097 unique references were identified, and 81 studies across 20 countries included, reporting on >11 million services prepandemic and 6.9 million during pandemic. For the primary outcome, there were 143 estimates of changes, with a median 37% reduction in services overall (IQR -51% to -20%), comprising median reductions for visits of 42% (-53% to -32%), admissions 28% (-40% to -17%), diagnostics 31% (-53% to -24%) and for therapeutics 30% (-57% to -19%). Among 35 studies reporting secondary outcomes, there were 60 estimates, with 27 (45%) reporting larger reductions in utilisation among people with a milder spectrum of illness, and 33 (55%) reporting no difference.
Healthcare utilisation decreased by about a third during the pandemic, with considerable variation, and with greater reductions among people with less severe illness. While addressing unmet need remains a priority, studies of health impacts of reductions may help health systems reduce unnecessary care in the postpandemic recovery.
CRD42020203729.
确定新冠疫情期间医疗服务利用情况变化的程度和性质。
系统评价。
符合条件的研究将新冠疫情期间的服务利用情况与前几年至少一个可比时期进行比较。服务包括就诊、住院、诊断和治疗。若研究来自单一中心或仅研究新冠患者,则被排除。
检索了PubMed、Embase、Cochrane新冠研究注册库和预印本,检索截至8月10日,无语言限制,使用包括新冠、卫生服务和影响等关键概念的详细检索式。
采用干预性非随机研究的偏倚风险工具和Cochrane有效实践与护理组织工具评估偏倚风险。结果采用描述性统计、图表和叙述性综合分析。
主要结局是疫情前和疫情期间服务利用情况的变化。次要结局是病情较轻或较重的医疗服务使用者比例的变化(如分诊评分)。
共识别出3097篇独特参考文献,纳入了20个国家的81项研究,报告了疫情前超过1100万次服务和疫情期间690万次服务。对于主要结局,有143项变化估计值,总体服务中位数减少37%(四分位间距为-51%至-20%),其中就诊中位数减少42%(-53%至-32%),住院减少28%(-40%至-17%),诊断减少31%(-53%至-24%),治疗减少30%(-57%至-19%)。在报告次要结局的35项研究中,有60项估计值,27项(45%)报告病情较轻者的服务利用减少幅度更大,33项(55%)报告无差异。
疫情期间医疗服务利用下降了约三分之一,存在相当大的差异,病情较轻者的减少幅度更大。虽然满足未满足的需求仍然是优先事项,但对服务减少的健康影响进行研究可能有助于卫生系统在疫情后恢复阶段减少不必要的医疗服务。
PROSPERO注册号:CRD42020203729。